Home
This site is intended for healthcare professionals
Advertisement

Carcinoma of unknown primary and TORS

9th Aug 2023
6:00 - 7:00pm (GMT)
9th Aug 2023
6:00 - 7:00pm (GMT)
Online event
This event has ended. Similar events
Free
ONLINE

Description

With the advent of minimally invasive transoral techniques, facilitated primarily through the introduction of TORS, we have seen an evolution in the management of the diagnostic and potential therapeutic management of HNSCC CUP. The webinar will provide a nuanced synopsis of recent evidence in this arena, including the prospective UK multicentre MOSES study, highlight trainee led collaborative research in HNSCC CUP led by INTEGRATE with recent partnership of NOTCH and the revised UK Multidisciplinary guidelines for HNSCC CUP.

TORS: Transoral robotic surgery

CUP: Carcinoma of Unknown Primary

HNSCC: Head and Neck Squamous Cell Cancer

MOSES:  Evaluation of the role of tongue base MucOsectomy and Step sErial Sectioning in the management of the unknown primary squamous cell cancer in the head and neck

INTEGRATE: UK ENT Trainee Research Network

NOTCH:  The National Oncology Trainees Collaborative for Healthcare Research

Learning Objectives

  • Understanding of current and future direction of CUP management
  • Role of tongue base mucosectomy
  • Controversies in CUP management
  • Current UK landscape in CUP management/research and consensus guidelines

Our panellists include:

John Hardman - John is a Specialty Registrar in North London who has recently been awarded a PhD in Surgeon-led multi-centre collaborative research, based at The Royal Marsden Hospital and The Institute of Cancer Research, under the supervision of Professor Vinidh Paleri and Professor Kevin Harrington. He helped establish INTEGRATE (The UK ENT Trainee Research Network) in 2015 and continues to have an interest in multi-centre research. His work on the MOSES Study and the INTEGRATE National Audit on HN SCC of unknown primary contributed to the consensus process to establish new guidelines for the management of unknown primary head and neck cancer in the UK. He is Deputy Chief Investigator for EVEREST-HN, an NIHR funded study to assess remote triage of suspected head and neck cancer referrals using patient-reported symptom-based risk stratification.

Somiah Siddiq - Somiah is a Consultant Head and Neck Surgeon and trust clinical lead for robotics at University Hospitals Birmingham (UHB), having undertaken fellowships at Tata Memorial Hospital, Mumbai and Freeman Hospital, Newcastle. Her clinical practice encompasses the management of Head and Neck & Thyroid malignancy with a specialist interest in minimally invasive surgery, establishing the Head and Neck Robotic programme in 2019. She is the local PI for the MOSES study, led the working group for management of neck metastases for the revised UK national multidisciplinary guidelines and a member of the NCRI working group to improve patient outcomes with locally advanced hypopharyngeal cancer. She serves as Editor in Chief to e-lefENT (the flagship e-learning platform for ENT UK), Honorary Senior Clinical Lecturer at Aston Medical School and EDI lead for BAHNO council.

Miss Nashreen Oozeer - Nashreen Oozeer is a H&N consultant at Sunderland Royal Hospital. She is a member of the RCSEd Otolaryngology Surgical Specialty Board and the H&N representative on the Robotic Taskforce. She is faculty on a number of national courses including the RCSEd Essentials in Robotics. She is the Patient Information lead for ENTUK and is actively involved in undergraduate and postgraduate training.

CPD

1 Hour

Summary

This live teaching session will help medical professionals learn how to identify carcinoma of unknown primary (CUP) and understand how transoral robotic surgery (TORS) may be used as a treatment option. Participants will be introduced to the key concepts of CUP and TORS research and will have the opportunity to share best practices with fellow professionals. This session will cover a range of topics, including recent evidence on CUP treatment, the current perspectives and techniques, and prognostic factors. Join us to gain insights into the current state of CUP treatment and the role of TORS as a potential therapeutic option.
Advertisement
Advertisement
View all

Similar events and on demand videos

Advertisement
 
9th Aug 2023
6:00 - 7:00pm (GMT)
Online event
This event has ended. Similar events
Free
ONLINE